L735,524 - THE RATIONAL DESIGN OF A POTENT AND ORALLY BIOAVAILABLE HIV PROTEASE INHIBITOR

被引:0
|
作者
DORSEY, BD
LEVIN, RB
MCDANIEL, SL
VACCA, JP
DARKE, PL
ZUGAY, JA
EMINI, EA
SCHLEIF, WA
QUINTERO, JC
LIN, JH
CHEN, IW
OSTOVIC, D
FITZGERALD, PMD
HOLLOWAY, MK
ANDERSON, PS
HUFF, JR
机构
[1] MERCK SHARP & DOHME LTD,DEPT MED CHEM,W POINT,PA 19486
[2] MERCK SHARP & DOHME LTD,DEPT MOLEC BIOL,W POINT,PA 19486
[3] MERCK SHARP & DOHME LTD,DEPT VIRUS & CELL BIOL,W POINT,PA 19486
[4] MERCK SHARP & DOHME LTD,DEPT DRUG METAB,W POINT,PA 19486
[5] MERCK SHARP & DOHME LTD,DEPT PHARMACEUT RES,W POINT,PA 19486
[6] MERCK SHARP & DOHME LTD,DEPT BIOPHYS CHEM,W POINT,PA 19486
[7] MERCK SHARP & DOHME LTD,DEPT MOLEC SYST,W POINT,PA 19486
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
引用
收藏
页码:6 / MEDI
相关论文
共 50 条
  • [31] The first total synthesis of (±)-arisugacin A, a potent, orally bioavailable inhibitor of acetylcholinesterase
    Sunazuka, T
    Handa, M
    Nagai, K
    Shirahata, T
    Harigaya, Y
    Otoguro, K
    Kuwajima, I
    Omura, S
    ORGANIC LETTERS, 2002, 4 (03) : 367 - 369
  • [32] Discovery of potent, orally bioavailable protease-activated receptor 4 antagonists
    Marinier, Anne
    Banville, Jacques
    Bird, Eileen
    Callejo, Mario
    Deon, Daniel
    Dube, Laurence
    Gagnon, Marc
    Giancarli, Mary
    Guy, Julia
    Harper, Tim
    Lam, Patrick
    Lavallee, Jean-Francois
    Lawrence, Michael
    Martel, Alain
    Miller, Michael
    O'Grady, Harold
    Posy, Shoshana
    Priestley, Scott
    Remillard, Roger
    Ruediger, Edward
    Tremblay, Francois
    Watson, Carol
    Wong, Pancras
    Yang, Jing
    Bouvier, Michel
    Seiffert, Dietmar
    Wexler, Ruth
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
  • [33] Identification of an Orally Bioavailable, Potent, and Selective Inhibitor of GlyT1
    Blackaby, Wesley P.
    Lewis, Richard T.
    Thomson, Joanne L.
    Jennings, Andrew S. R.
    Goodacre, Simon C.
    Street, Leslie J.
    MacLeod, Angus M.
    Pike, Andrew
    Wood, Suzanne
    Thomas, Steve
    Brown, Terry A.
    Smith, Alison
    Pillai, Gopalan
    Almond, Sarah
    Guscott, Martin R.
    Burns, H. Donald
    Eng, Waisi
    Ryan, Christine
    Cook, Jacquelynn
    Hamill, Terence G.
    ACS MEDICINAL CHEMISTRY LETTERS, 2010, 1 (07): : 350 - 354
  • [34] Discovery of PF-04449913, a Potent and Orally Bioavailable Inhibitor of Smoothened
    Munchhof, Michael J.
    Li, Qifang
    Shavnya, Andrei
    Borzillo, Gary V.
    Boyden, Tracey L.
    Jones, Christopher S.
    LaGreca, Susan D.
    Martinez-Alsina, Luis
    Patel, Nandini
    Pelletier, Kathleen
    Reiter, Larry A.
    Robbins, Michael D.
    Tkalcevic, George T.
    ACS MEDICINAL CHEMISTRY LETTERS, 2012, 3 (02): : 106 - 111
  • [35] Design and Optimization of Potent and Orally Bioavailable Tetrahydronaphthalene Raf Inhibitors
    Gould, Alexandra E.
    Adams, Ruth
    Adhikari, Sharmila
    Aertgeerts, Kathleen
    Afroze, Roushan
    Blackburn, Christopher
    Calderwood, Emily F.
    Chau, Ryan
    Chouitar, Jouhara
    Duffey, Matthew O.
    England, Dylan B.
    Farrer, Cheryl
    Forsyth, Nancy
    Garcia, Khristofer
    Gaulin, Jeffery
    Greenspan, Paul D.
    Guo, Ribo
    Harrison, Sean J.
    Huan, Shih-Chung
    Iartchouk, Natalia
    Janowick, Dave
    Kim, Mi-Sook
    Kulkarni, Bheemashankar
    Langston, Steven P.
    Liu, Jane X.
    Ma, Li-Ting
    Menon, Saurabh
    Mizutani, Hirotake
    Paske, Erin
    Renou, Christelle C.
    Rezaei, Mansoureh
    Rowland, R. Scott
    Sintchak, Michael D.
    Smith, Michael D.
    Stroud, Stephen G.
    Tregay, Ming
    Tian, Yuan
    Veiby, Ole P.
    Vos, Tricia J.
    Vyskocil, Stepan
    Williams, Juliet
    Xu, Tianlin
    Yang, Johnny J.
    Yano, Jason
    Zeng, Hongbo
    Zhang, Dong Mei
    Zhang, Qin
    Galvin, Katherine M.
    JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (06) : 1836 - 1846
  • [36] New series of potent, orally bioavailable, non-peptidic cyclic sulfones as HIV-1 protease inhibitors
    Kim, CU
    McGee, LR
    Krawczyk, SH
    Harwood, E
    Harada, Y
    Swaminathan, S
    Bischofberger, N
    Chen, MS
    Cherrington, JM
    Xiong, SF
    Griffin, L
    Cundy, KC
    Lee, A
    Yu, B
    Gulnik, S
    Erickson, JW
    JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (18) : 3431 - 3434
  • [37] Design, synthesis, and optimization of novel PD-L1 inhibitors and the identification of a highly potent and orally bioavailable PD-L1 inhibitor
    Ruengsatra, Tanachote
    Soponpong, Jakapun
    Nalinratana, Nonthaneth
    Jirapongwattana, Niphat
    Dunkoksung, Wilasinee
    Rattanangkool, Eakkaphon
    Deesiri, Sirikan
    Srisa, Jakkrit
    Songthammanuphap, Songkiat
    Udomnilobol, Udomsak
    Prueksaritanont, Thomayant
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 277
  • [38] Rational design of a novel, potent, and orally bioavailable cyclohexylamine DPP-4 inhibitor by application of molecular modeling and X-ray crystallography of sitagliptin
    Biftua, Tesfaye
    Scapin, Giovanna
    Singh, Suresh
    Feng, Dennis
    Becker, Joe W.
    Eiermann, George
    He, Hualbing
    Lyons, Kathy
    Patel, Sangita
    Petrov, Aleksandr
    Sinha-Roy, Ranabir
    Zhang, Bei
    Wu, Joseph
    Zhang, Xiaoping
    Doss, George A.
    Thornberry, Nancy A.
    Weber, Ann E.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (12) : 3384 - 3387
  • [39] DESIGN AND SYNTHESIS OF LY289612, A POTENT INHIBITOR OF HIV PROTEASE
    KALDOR, SW
    HAMMOND, M
    DRESSMAN, BA
    FRITZ, JE
    CROWELL, TA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1993, 206 : 138 - MEDI
  • [40] AB474, a potent orally bioavailable inhibitor of arginase, for the treatment of cancer
    Eckard, Sterling C.
    Chen, Yu
    Piovesan, Dana
    Narasappa, Nell
    Park, Timothy W.
    Kalisiak, Jarek
    Newcomb, Eric T.
    Leleti, Manmohan R.
    Soni, Divyank
    Ginn, Elaine
    Chen, Jie
    DiRenzo, Dan
    Zhang, Kristen
    Jin, Lixia
    Young, Stephen W.
    Walters, Matthew J.
    Schindler, Ulrike
    Powers, Jay P.
    CANCER RESEARCH, 2019, 79 (13)